icrn webinar: "what is idh1 mutated cholangiocarcinoma and what else can we do for it?”
Published 3 years ago • 388 plays • Length 49:48Download video MP4
Download video MP3
Similar videos
-
1:04:34
icrn webinar: morphomolecular characterization of early and progressed cholangiocarcinoma
-
57:38
icrn webinar: "meki – where do we go next in cholangiocarcinoma?”
-
1:02:13
icrn webinar: "innovative surgical approaches to cholangiocarcinoma – transplant and beyond”
-
59:21
icrn webinar: supermassive intrahepatic cca: clinicogenomic analysis & role of ablative radiotherapy
-
40:50
icrn webinar: drug repurposing in cholangiocarcinoma – identifying leads from the literature
-
38:40
icrn: ablative radiation for intrahepatic cholangiocarcinoma: current status & future directions
-
7:54
ivosidenib for patients with idh1-mutated cholangiocarcinoma
-
59:37
icrn/ens-cca translational science webinar series: "role of cytotoxic chemo in cholangiocarcinoma”
-
1:01:02
webinar: radiation therapy and molecular characterization of cholangiocarcinoma
-
56:28
webinar: “the perio-02 trial – enabling immunotherapy for intrahepatic cholangiocarcinoma”
-
58:24
webinar: hepatic arterial infusion (hai) pump trial for icc at ohsu
-
57:28
icrn/ens-cca translational science webinar series: "next steps with fgfri”
-
58:22
icrn webinar: arid1a and cca
-
35:30
ac22 - cholangiocarcinoma updates panel discussion
-
17:37
apcca2019_009_session 1: what is the best approach for biopsy and stenting hilar cholangiocarcinoma?
-
59:37
icrn: introduction to cbioportal for cancer genomics
-
12:47
ac21 - mitesh borad: updates on genomically formed therapy in cca - idh1/idh2
-
59:47
oncogenomics in cholangiocarcinoma: patient stratification and predictive biomarkers
-
1:04:29
icrn/ens-cca webinar: "challenges of designing immune trials in the second line with review of data"